Atara Biotherapeutics, Inc. (ATRA) vs Rani Therapeutics Holdings, Inc. (RANI)
- Atara Biotherapeutics, Inc. ATRA 9.18 −4.87%
- Rani Therapeutics Holdings, Inc. RANI 0.64 −5.88%
Atara Biotherapeutics, Inc. and Rani Therapeutics Holdings, Inc. are both Biotechnology companies. Atara Biotherapeutics, Inc. and Rani Therapeutics Holdings, Inc. are of similar size ($96.9M and $94.8M). Rani Therapeutics Holdings, Inc. grew revenue faster over the last twelve months: 78.7% against −96.7%. Atara Biotherapeutics, Inc. has the higher net margin (−269.4% vs −597.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Atara Biotherapeutics, Inc. leads on 10 and Rani Therapeutics Holdings, Inc. on 4.
Valuation
Profitability
| Metric | ATRA | RANI | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.38% | 100.00% | 65.16% |
| Operating margin | (229.67%) | (652.78%) | 0.00% |
| Net margin | (269.42%) | (596.97%) | 0.00% |
| Free cash flow margin | (353.49%) | (402.83%) | 0.00% |
| Return on equity | 46.33% | (155.24%) | (56.36%) |
| Return on assets | (57.62%) | (77.54%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack